Compile Data Set for Download or QSAR
Report error Found 222 of affinity data for UniProtKB/TrEMBL: Q13724
TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689894(US20240262819, Example 38 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.0500nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689869(US20240262819, Example 13 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.0600nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689954((S)-quinuclidin-3-yl((R)-5-(2-chloro-4-(cyclopropy...)
Affinity DataIC50: 0.0600nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689948((S)-quinuclidin-3-yl((R)-5-(2-chloro-4-isopropoxyp...)
Affinity DataIC50: 0.0700nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689913(US20240262819, Example 57 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.0800nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689952((S)-quinuclidin-3-yl((R)-6-fluoro-5-(4-isopropoxy-...)
Affinity DataIC50: 0.0800nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689960((S)-quinuclidin-3-yl((R)-5-(2-chloro-4-ethoxypheny...)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689926(US20240262819, Example 70 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.120nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689892(US20240262819, Example 36 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.130nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689916(US20240262819, Example 60 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.130nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689924(US20240262819, Example 68 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.140nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690025((S)-quinuclidin-3-yl((R)-6-(4-ethyl-3-fluorophenyl...)
Affinity DataIC50: 0.140nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689925(US20240262819, Example 69 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.150nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689900(US20240262819, Example 44 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.170nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690002((S)-quinuclidin-3-yl((R)-6-(4-isobutoxyphenyl)-2,2...)
Affinity DataIC50: 0.170nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690024((S)-quinuclidin-3-yl((R)-6-(2-chloro-4-isopropoxyp...)
Affinity DataIC50: 0.188nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689958((S)-quinuclidin-3-yl((R)-5-(4-(tert-butoxy)-2-chlo...)
Affinity DataIC50: 0.190nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690027((S)-quinuclidin-3-yl((R)-7-fluoro-2,2-dimethyl-6-(...)
Affinity DataIC50: 0.190nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690035((S)-quinuclidin-3-yl((R)-7-fluoro-6-(4-isobutoxyph...)
Affinity DataIC50: 0.190nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689888(US20240262819, Example 32 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.192nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690055((S)-quinuclidin-3-yl((R)-6-(2-chloro-4-isopropoxyp...)
Affinity DataIC50: 0.192nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689864(US20240262819, Example 8 | (S)-quinuclidin-3-yl((R...)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689970((S)-quinuclidin-3-yl((R)-5-(2-chloro-4-(2,2,2-trif...)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689974((S)-quinuclidin-3-yl((R)-5-(4-butylphenyl)-2,2,6-t...)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689980((S)-quinuclidin-3-yl((R)-5-(4-isobutoxyphenyl)-2,2...)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690053((S)-quinuclidin-3-yl((R)-7-fluoro-6-(4-isopropoxyp...)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690034((S)-quinuclidin-3-yl((R)-6-(4-butoxyphenyl)-7-fluo...)
Affinity DataIC50: 0.220nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689975((S)-quinuclidin-3-yl((R)-5-(4-isobutylphenyl)-2,2,...)
Affinity DataIC50: 0.230nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689998((S)-quinuclidin-3-yl((R)-6-(4-butylphenyl)-2,2-dim...)
Affinity DataIC50: 0.230nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689959((S)-quinuclidin-3-yl((R)-5-(2-chloro-4-methoxyphen...)
Affinity DataIC50: 0.240nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689979((S)-quinuclidin-3-yl((R)-5-(4-butoxyphenyl)-2,2,6-...)
Affinity DataIC50: 0.240nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690029((S)-quinuclidin-3-yl((R)-6-(4-butylphenyl)-7-fluor...)
Affinity DataIC50: 0.240nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690032((S)-quinuclidin-3-yl((R)-6-(4-ethoxyphenyl)-7-fluo...)
Affinity DataIC50: 0.240nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689914(US20240262819, Example 58 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.25nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690033((S)-quinuclidin-3-yl((R)-7-fluoro-2,2-dimethyl-6-(...)
Affinity DataIC50: 0.25nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689995((S)-quinuclidin-3-yl((R)-6-(4-ethylphenyl)-2,2-dim...)
Affinity DataIC50: 0.260nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689912(US20240262819, Example 56 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.270nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689915(US20240262819, Example 59 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.280nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689977((S)-quinuclidin-3-yl((R)-2,2,6-trimethyl-5-(4-prop...)
Affinity DataIC50: 0.280nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690031((S)-quinuclidin-3-yl((R)-7-fluoro-6-(4-methoxyphen...)
Affinity DataIC50: 0.280nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689859(US20240262819, Example 3 | (S)-quinuclidin-3-yl((R...)
Affinity DataIC50: 0.290nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689940(US20240262819, Example 84 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.290nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689996((S)-quinuclidin-3-yl((R)-2,2-dimethyl-6-(4-propylp...)
Affinity DataIC50: 0.290nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690001((S)-quinuclidin-3-yl((R)-6-(4-butoxyphenyl)-2,2-di...)
Affinity DataIC50: 0.290nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689898(US20240262819, Example 42 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.300nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689918(US20240262819, Example 62 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.300nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690040((S)-quinuclidin-3-yl((R)-7-fluoro-6-(3-methoxyphen...)
Affinity DataIC50: 0.300nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM690041((S)-quinuclidin-3-yl((R)-6-(3-ethoxyphenyl)-7-fluo...)
Affinity DataIC50: 0.300nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689931(US20240262819, Example 75 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.310nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

TargetMannosyl-oligosaccharide glucosidase(Human)
YUHAN CORPORATION; GREEN CROSS CORPORATION

US Patent
LigandPNGBDBM689933(US20240262819, Example 77 | (S)-quinuclidin-3-yl((...)
Affinity DataIC50: 0.310nMAssay Description:The inhibitory activities of the compounds of the present invention against GCS were evaluated, as follows, according to the method described in the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
US Patent

Displayed 1 to 50 (of 222 total ) | Next | Last >>
Jump to: